The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan

Although routine vaccinations in children decreased during the coronavirus disease 2019 (COVID-19) pandemic, pneumococcal vaccine coverage in older adults has remained unknown. This study was performed to investigate the impact of the COVID-19 pandemic on pneumococcal vaccination in Japan. The numbe...

Full description

Saved in:
Bibliographic Details
Main Authors: Akira Komori (Author), Hirotake Mori (Author), Toshio Naito (Author)
Format: Book
Published: Taylor & Francis Group, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_2a01fcb51c8349a4852958e7395169a9
042 |a dc 
100 1 0 |a Akira Komori  |e author 
700 1 0 |a Hirotake Mori  |e author 
700 1 0 |a Toshio Naito  |e author 
245 0 0 |a The COVID-19 pandemic increased the demand for pneumococcal vaccination in Japan 
260 |b Taylor & Francis Group,   |c 2021-11-01T00:00:00Z. 
500 |a 2164-5515 
500 |a 2164-554X 
500 |a 10.1080/21645515.2021.1958612 
520 |a Although routine vaccinations in children decreased during the coronavirus disease 2019 (COVID-19) pandemic, pneumococcal vaccine coverage in older adults has remained unknown. This study was performed to investigate the impact of the COVID-19 pandemic on pneumococcal vaccination in Japan. The numbers of 23-valent pneumococcal polysaccharide vaccines (PPV23) shipped was obtained from an office memorandum released by the Ministry of Health, Labor and Welfare. The results showed that the COVID-19 pandemic increased the need for pneumococcal vaccination, causing shipping restrictions of pneumococcal vaccines. Regular vaccination is still important because there may be a shortage of vaccines during a pandemic. 
546 |a EN 
690 |a covid-19 
690 |a pandemic 
690 |a pneumococcal vaccination 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4673-4674 (2021) 
787 0 |n http://dx.doi.org/10.1080/21645515.2021.1958612 
787 0 |n https://doaj.org/toc/2164-5515 
787 0 |n https://doaj.org/toc/2164-554X 
856 4 1 |u https://doaj.org/article/2a01fcb51c8349a4852958e7395169a9  |z Connect to this object online.